NCT04275843

Brief Summary

The Western diet pattern or standard American diet is a modern dietary pattern that is characterized by high intakes of meat, pre-packaged foods, fried foods, high-fat dairy products, eggs, refined grains etc. When considering the role of saturated fat, it may be prudent to advise limiting all foods that contain saturated fats, including unprocessed/minimally processed meat, eggs, whole dairy in addition to processed, pre-packaged foods; however, this reductionist approach fails to take into account the food matrix and overall diet in which these nutrients are consumed. Epidemiological evidence suggests that increased modern, pre-packaged food consumption is a major risk factor for metabolic disease by promoting inflammation. Based on these data, the investigators hypothesize that the pro-atherogenic effect of the Western diet is caused by the pro-inflammatory effects of consuming large amounts of modern ultra-processed foods, and that consumption of a similar amount of fat from minimally processed beef, poultry, dairy, eggs, as part of an unprocessed diet will positively impact inflammatory markers and lipoprotein profiles of study participants when compared to a diet rich in modern ultra-processed foods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 19, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2021

Completed
Last Updated

July 13, 2022

Status Verified

January 1, 2022

Enrollment Period

1.2 years

First QC Date

February 7, 2020

Last Update Submit

July 11, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in plasma interleukin-6 levels

    Plasma interleukin-6 levels will be measured before and after each diet

    Baseline, up to 4 weeks.

  • Change in plasma c-reactive protein levels

    Plasma c-reactive protein levels levels will be measured before and after each diet

    Baseline, up to 4 weeks.

  • Change in plasma acylcarnitine profiles

    Plasma acylcarnitines profiles levels will be measured before and after each diet

    Baseline, up to 4 weeks.

Secondary Outcomes (3)

  • Change in gut microbiota communities

    Baseline, up to 4 weeks.

  • Energy expenditure

    up to 4 weeks.

  • Change in Neuroinflammation

    Baseline, up to 4 weeks.

Study Arms (2)

Traditional Diet

ACTIVE COMPARATOR

Unprocessed/minimally processed whole foods.

Dietary Supplement: Traditional Diet

Modern Diet

ACTIVE COMPARATOR

Multi-ingredient, ultra-processed formulations of the traditional diet.

Dietary Supplement: Modern Diet

Interventions

Traditional DietDIETARY_SUPPLEMENT

Consuming an traditional whole foods based diet for 4 weeks.

Traditional Diet
Modern DietDIETARY_SUPPLEMENT

Consuming an processed formulation of the traditional diet for 4 weeks.

Modern Diet

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age ≥35 and ≤60 years;
  • BMI ≥25 and ≤35 kg/m2;
  • Weight stable in last 3 months (Loss or gain \<4%);
  • Consistent physical activity levels;
  • Hemoglobin A1C (HbA1C) ≤6.4%;
  • Fasting insulin; \<15 µU/mL;
  • Fasting plasma glucose concentration \<126 mg/dl;
  • Willingness to eat the food provided in this study;
  • Subjects must be able to speak and understand English to participate in this study
  • Own a smartphone or other mobile device capable of downloading the Garmin Connect app.

You may not qualify if:

  • Diagnoses of active malignancy, congestive heart failure, diabetes mellitus, chronic obstructive pulmonary disease, thyroid disease or other metabolic disorders that influence metabolism;
  • Evidence of impaired kidney function (Estimated glomerular filtration rate \[eGFR\] \<44 mL/min;
  • Regular use of medication that interferes with the measurement of study outcomes as determined by the study team (e.g., NSAIDs, corticosteroids);
  • Consuming \>14 drinks per week of \>4 drinks per night twice/week for male; \>7 drinks per week or \>3 drinks per night twice/week for female;
  • Use of cigarettes (or other tobacco products) or use of any other (recreational) drug in last 3 months;
  • Engaged in high-level competitive exercise (e.g., marathons, triathlons, cycling, weight-lifting competitions etc.)
  • Self-reported sleep duration \<5 hours per night;
  • Any inflammatory diseases (e.g. asthma, autoimmune diseases, coeliac disease, glomerulonephritis, hepatitis, inflammatory bowel disease, arthritis);
  • Use of antibiotics in last 30 days;
  • Pregnant or lactating women;
  • Eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorders etc.)
  • Psychological disorders (e.g., clinical depression, bipolar disorders etc.);
  • Strict dietary patterns (e.g., vegan, carnivore, kosher, low-carb etc.);
  • History of stomach or bowel resection (other than appendectomy), gastric bypass or other bariatric weight loss procedure effecting absorption;
  • Persons who are not able to grant voluntary informed consent;
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University School of Medicine

Durham, North Carolina, 27701, United States

Location

Study Officials

  • Stephan van Vliet, PhD

    Duke University

    STUDY DIRECTOR
  • Kim Huffman, MD, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
As this is feeding study with two very much different diets, participants and investigators were not blinded. The Core facilities that are analyzing de-identified coded samples and remain blinded to treatments.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2020

First Posted

February 19, 2020

Study Start

October 1, 2020

Primary Completion

December 21, 2021

Study Completion

December 21, 2021

Last Updated

July 13, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations